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800Objective: This study relates long-term mortality after cardiac surgery to different methods of measuring post-
operative renal function, classified according to the Risk, Injury, Failure, Loss, and End-stage (RIFLE) criteria.
The dynamics of acute kidney injury during hospital stay were studied by comparing renal function preopera-
tively, at its poorest measurement, and at discharge.
Methods:A total of 5746 patients undergoing coronary artery bypass grafting were studied in a Cox analysis,
over a median follow-up time of 6.0 years (range, 2.5-9.5 years). Renal function was determined using the
highest and discharge levels of plasma creatinine by Cockroft–Gault and Modification of Diet in Renal Dis-
ease formulae. Acute kidney injury was classified according to the RIFLE criteria. Renal recovery was studied
in a 2-dimensional matrix, and the impact of renal function at different time points was related to survival.
Results: Although the p-creatinine classified most patients in the nonacute kidney injury and Risk class; the
Cockroft–Gault and Modification of Diet in Renal Disease formulae classified more patients in Injury and
Failure classes; and higher Risk, Injury, and Failure classes were associated with increased long-term mortal-
ity. The effect of renal recovery on long-term survival was only in part associated with improved outcome. In
addition, the poorest renal function was a stronger predictor of mortality compared with preoperative and
discharge levels.
Conclusions: Classification using RIFLE criteria seems to be useful because it detects patients with renal impair-
ment that affects long-term survival. The Modification of Diet in Renal Disease method seems to be the most
robust method when predicting outcome, and the poorest renal function was the best predictor of outcome. Renal
recovery was generally associated with better outcome. (J Thorac Cardiovasc Surg 2014;147:800-7)Acute kidney injury (AKI) is common after cardiac surgery,
and incidences between 7% and 40% have been reported
depending on the definition used.1-4 AKI has well-
documented negative effects on postoperative morbidity
and mortality,5 as well as the length of postoperative hospi-
tal stay and costs.6 In clinical practice, it is not obvious how
this powerful predictor should be handled in a useful way.
First, almost all centers use the p-creatinine concentration
for estimating glomerular renal filtration (GFR), and the
shortcomings of this marker are well known.7 To compen-
sate for this, different formulae have been constructedwhere
other physiologic variables are introduced. The Cockroft–
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The Journal of Thoracic and Cardiovascular Surg(MDRD) formulae are 2 commonly used examples. The first
expresses renal function as estimated creatinine clearance
(eCrCl) and the latter as estimated glomerular filtration
rate (eGFR). The MDRD formula has been widely used in
studies in cardiac surgery.8-14 P-creatinine, eCrCl, and
eGFR are still only estimates of true GFR.
A second challenge is that during and after cardiac sur-
gery, renal function varies on a daily basis.15,16 Several
authors have highlighted the observation that decreased
renal function after cardiac surgery affects both short- and
long-term mortality.10,11,17-20 The majority of these
studies have mainly focused on the poorest renal function.
However, some patients with AKI recover completely
during their hospital stay, whereas others show no
recovery at all. Earlier studies demonstrate conflicting
results on renal recovery and long-term outcome. There-
fore, there is a need for more studies on the dynamics of
renal function after cardiac surgery.
The aim of this study was 2-fold. The primary objective
was to assess the importance of time point for measuring,
and consequently the dynamics of renal recovery in relation
to long-termmortality. The secondary aim was to compare 3
different plasma creatinine-based assessments of renal func-
tion (ie, absolute p-creatinine concentrations, eCrCl using
theCG formula, and eGFR according to theMDRD formula)ery c February 2014
Abbreviations and Acronyms
AKI ¼ acute kidney injury
CABG ¼ coronary artery bypass grafting
CG ¼ Cockroft–Gault
CI ¼ confidence interval
eCrCl ¼ estimated creatinine clearance
eGFR ¼ estimated glomerular filtration rate
GFR ¼ glomerular filtration rate
HR ¼ hazard ratio
IABP ¼ intra-aortic balloon pump
MDRD ¼ Modification of Diet in Renal Disease
RIFLE ¼ Risk, Injury, Failure, Loss, and End-stage
Dardashti et al Perioperative Managementusing the Risk, Injury, Failure, Loss, and End-stage (RIFLE)
criteria to find the best method for renal assessment.P
MMATERIALS AND METHODS
Study Design
The study was approved by the local ethics committee. All patients who
had undergone cardiac surgery at the Department of Cardiothoracic Sur-
gery at the University Hospital in Lund, Sweden, between January 1,
2002, and December 31, 2008, were included.
Database Management
Data weremainly collected from the hospital’s quality-control database,
in which information is continuously collected on perioperative care during
patients’ hospital stays. Other sources of data were the blood bank and clin-
ical chemistry databases at the hospital. Survival or time of death for each
patient was determined from the national tax registry inMay 2011, defining
the follow-up period from 2.5 to 9.5 years. Where data were missing or
extreme outliers were identified, patient records were read to complete
the database. In cases of data mismatch between different data sources,
the data were manually checked by consulting the patient’s records.
After completingmissing data from patient records, preoperative p-creat-
inine values were still missing in 104 patients. For these patients, the preop-
erative p-creatinine level was estimated using an imputation technique based
on the p-creatinine level 1 day after surgery. The formula usedwas creatinine
day 0¼ 15.0þ (0.863 creatinine day 1), calculated by applying regression
analysis to the relation between the preoperative p-creatinine level (on day 0)
and the p-creatinine 1 day after surgery (day 1).21,22
Patient Inclusion and Exclusion
All patients who had undergone coronary artery bypass grafting
(CABG) as the sole surgical intervention between January 1, 2002, and
December 31, 2008, were included. The following predetermined
exclusion criteria were used: emergency operation (defined as operation
within 1 hour of the decision to operate) (n ¼ 125, 2.1%), preoperative
eGFR (MDRD)<15 mL/min (n ¼ 20, 0.3%), and death within 7 days of
operation (n ¼ 51, 0.9%) because we aimed to study long-term outcomes,
and patients who die early most often have major cerebral or cardiac insult
and seldom die of AKI due to available renal replacement therapies. Of a
total of 5943 patients, 5746 constituted the study group after application
of the exclusion criteria.
Measurements of Renal Function
Kidney function was based on p-creatinine levels, the absolute p-creat-
inine value, eGFR,9 or the eCrCl.23 Changes in p-creatinine, eGFR, andThe Journal of Thoracic and CaeCrCl during the hospital stay were compared with the preoperative values
(baseline value) to assess changes in kidney function. The commonly used
MDRD formula used is as follows:
eGFR mL/min/1.73 m2 ¼ 32,788 3 p-creatinine1.154 3 age0.203 3
[1.210 if black] 3 [0.742 if female].9,24
In our population, the number of black patients is less than 1% and not
recorded in journals. Therefore, we used the original formula with only that
adjustment: eGFR ¼ 32,788 3 p-creatinine1.154 3 age0.203 3 [0.742 if
female]. The CG formula used was as follows:
eCrCl (female) mL/min¼ ([140-age]3weight in kg3 1.04 )/(p-creat-
inine in mmol/L) or eCrCl (male) mL/min ¼ ([140-age] 3 weight in
kg 3 1.23 )/(p-creatinine in mmol/L).23
eGFR and eCrCl values calculated on the highest concentration of post-
operative p-creatinine (p-creatininepeak) are denoted as eGFRpeak and
eCrClpeak, respectively. In line with this, eGFR and eCrCl values calculated
on the level of p-creatinine closest to the day of discharge from hospital
(p-creatininedischarge) are denoted as eGFRdischarge and eCrCldischarge,
respectively.
We assumed that the ‘‘peak’’ values corresponded to the poorest kidney
function and ‘‘discharge’’ values to the level of kidney function at the time
of discharge from hospital. All p-creatinine concentrations were deter-
mined with the enzymatic colorimetric method25 with a 1.4% to 1.7%
coefficient of variance. The reference method for determination of the cali-
brator used was isotope dilution/mass spectrometry.
Definition of Acute Kidney Injury
AKI was classified using the RIFLE scale.26 The RIFLE staging
was made according to changes in levels of kidney function measured
by p-creatinine, eGFR, and eCrCl (Table 1). Urinary output data were
not available, so we used only the p-creatinine–based RIFLE
classifications.
Statistics
The Student t test was used for group comparisons. Unless otherwise
stated, values are presented as the mean 1 standard deviation. Unadjusted
Kaplan–Meier curves were used to show differences in survival between
groups. The Cox proportional hazard model was used to determine which
factors had an adverse outcome on long-term survival in all survival anal-
ysis. Wald statistics were used to determine the strength of a relation. The
increased risk for mortality during the study period expressed as adjusted
hazard ratio (HR) obtained from the multivariate Cox proportional hazard
model was used to compare relative risks between groups. On the basis of
previous studies on the subject, the following variables were entered into
the Cox analysis8,27-29: history of cerebrovascular disease, diabetes, or
chronic obstructive pulmonary disease; female gender; peripheral
vascular disease; left ventricular ejection fraction 30% to 50%; left
ventricular ejection fraction less than 30%; age; intra-aortic balloon
pump (IABP) before surgery; IABP after surgery; previous percutaneous
coronary intervention; postoperative myocardial infarction; postoperative
sepsis; postoperative stroke; reoperation due to bleeding; postoperativeme-
diastinitis or postoperative atrial fibrillation; body mass index; time on
ventilator; and transfusion of red blood cells, plasma, and platelets. In addi-
tion to these risk factors, measures of renal function were entered depend-
ing on which RIFLE group of patients was being analyzed and which
method was used for determining RIFLE group. HRs were estimated using
patients classified as non-AKI as a reference for each method used for
defining AKI respectively.
Statistical analysis was performed with Statistica software version 9.0
(StatSoft, Inc, Tulsa, Okla) for most of the analyses. The R-project (version
1.13.0) software with the survival packagewas used to test the proportional
hazard assumption for a Cox regression model fit.
To study the effect of renal recovery, a 2-dimensional matrixwas created
in which 1 dimension was RIFLEpeak and the other was RIFLEdischarge,
based on MDRD eGFR.rdiovascular Surgery c Volume 147, Number 2 801
TABLE 1. Classification of acute kidney injury using the RIFLE classification system
Non-AKI Risk Injury Failure
Creatinine <50% creatinine increase 50%-100% creatinine increase 100%-150% creatinine increase >150% creatinine increase or
p-creatinine>350 mmol/L
MDRD eGFR <25% eGFR decrease 25%-50% eGFR decrease 50%-75% eGFR decrease >75% eGFR decrease or
preoperative p-creatinine
>350 mmol/L
CG eCrCl <25% eCrCl decrease 25%-50% eCrCl decrease 50%-75% eCrCl decrease >75% eCrCl decrease or
preoperative p-creatinine
>350 mmol/L
AKI, Acute kidney injury;CG, Cockroft–Gault; eCrCl, estimated creatinine clearance; eGFR, estimated glomerular filtration rate;MDRD, Modification of Diet in Renal Disease;
RIFLE, Risk, Injury, Failure, Loss, and End-stage.
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MTo evaluate the relative strength in predicting outcome for renal function
at different time points (before surgery, poorest renal function, and
discharge), we performed a multivariate Cox survival analysis where
eGFR represented preoperative levels; poorest renal function and discharge
were entered as continuous variables in our model.
RESULTS
A total of 5746 patients were analyzed over a median
follow-up time of 6.0 years (range, 2.5-9.5 years). The gen-
eral characteristics and outcome of the cohort are presented
in Table 2. The incidence of postoperative AKI (RIFLE
classes R, I, and F) varied depending on the method used
to determine renal function. The number of patients classi-
fied as non-AKI differed depending on the time point (ie,
peak or discharge) and method of measuring renal function
(ie, p-creatinine, eCrCl, or eGFR). The lowest number was
found using eGFR, and the highest number was found using
p-creatinine as presented in Tables 3 and 4.
RIFLE Classification Based on Poorest Renal
Function
By comparing the 3methods of renal functionmeasuring,
the eGFRpeak method yielded the highest number of patients
with AKI, whereas the lowest number of patients classified
with AKI was found in the p-creatininepeak group. The risk
of mortality during the study period, expressed as HR,
increased significantly in all RIFLE classes compared
with non-AKI for all 3 expressions of renal function
(Table 3 and Figure 1). The HR increased with more severe
RIFLE class (ie, HR for RIFLE class F>I>R>non-AKI),
with eGFRpeak F as the only exception. Using the eGFRpeak
and eCrClpeak led tomore patients being classified as RIFLE
classes R, I, and F than when p-creatininepeak was used.
RIFLE Classification Based on Renal Function at
Discharge
More patients were classified in RIFLE classes R, I, and F
when using eCrCldischarge or eGFRdischarge than when using
p-creatininedischarge. In addition, eGFRdischarge led to more
patients being classified as AKI than eCrCl and p-creatinine
(Table 4). HR increased progressively with more serious802 The Journal of Thoracic and Cardiovascular SurgRIFLE class only in the eGFRdischarge measures. Classifica-
tion using p-creatininedischarge and eCrCldischarge showed a
progressive increase in HR compared with non-AKI in RI-
FLE classes R and I, but the value of HR decreased in RI-
FLE class F. With p-creatininedischarge RIFLE class F as
the only exception, all HRs in RIFLE classes R, I, and F
for all 3 methods were significantly higher compared with
non-AKI, respectively.
Dynamics of Renal Recovery and Its Impact on
Survival
A 2-dimensional matrix in which 1 dimension was RI-
FLEpeak and the other was RIFLEdischarge, both based on
eGFR, was constructed to demonstrate the effect of recov-
ery (Table 5). The HR for long-term mortality for all post-
operative AKI (RIFLE classes R, I, and F) with or
without recovery was 1.56 (confidence interval [CI], 1.37-
1.77; P< .001). The HR for patients with any degree of
AKI who showed complete recovery to non-AKI was 1.42
(CI, 1.21-1.66; P<.001). The HR for patients with any de-
gree of remaining AKI at dischargewas 1.69 (CI, 1.44-1.99;
P<.001). Long-term mortality HR for patients who recov-
ered to non-AKI at discharge was not increased if eGFRpeak
had been RIFLE R. However, if eGFRpeak classified the
patients as RIFLE I or F, it resulted in an increased HR,
where RIFLEpeak I had an HR 1.58 (CI, 1.18-2-10;
P ¼ .002), and those classified as RIFLEpeak F had an HR
2.53 (CI, 1.84-3.48; P<.001).
Relative Importance of Renal Function at Different
Time Points
In a separate survival analysis where the 3 values of
eGFR for preoperative (eGFRpreoperative) levels, levels for
poorest renal function (eGFRpeak), and levels at discharge
(eGFRdischarge) were entered separately, the eGFRpeak levels
contributed the most to the model and were thus the most
predictive for outcome. The HR for eGFRpreoperative was
0.99 (P<.0001; Wald ¼ 32.91), the HR for eGFRdischarge
was 0.98 (P < .0001; Wald ¼ 44.98), and the HR for
eGFRpeak was 0.98 (P<.0001; Wald ¼ 80.16).ery c February 2014
TABLE 2. Preoperative characteristics and outcomes of the entire
study cohort presented as mean (standard deviation) for continuous
variables or number (percent) for dichotomous variables
Characteristic No.
Mean (SD) or
n (%)
Age 5742 67.3 (9.7)
Female gender 5742 1293 (22.5)
Body mass index 5735 27.1 (4)
Diabetes 5742 1270 (2)
History of cerebrovascular injury 5742 520 (9)
Previous vascular surgery 5742 520 (9)
COPD 5742 529 (9.2)
Peripheral vascular disease 5742 821 (14)
Previous myocardial infarction 5742 2567 (44.7)
LVEF 30%-50% 5742 1589 (27.7)
LVEF<30% 5742 371 (6.5)
IABP before surgery 5742 170 (3)
Previous CABG 5742 120 (2.1)
Previous PCI 5742 684 (11.9)
EuroSCORE, additive 5742 4.8 (3.3)
NYHA class
I 5742 1375 (24)
II 5742 1900 (33.1)
III 5742 1781 (31)
IV 5742 685 (11.9)
CCS class
I 5742 214 (3.7)
II 5742 1892 (33.0)
III 5742 2464 (42.9)
IV 5742 1167 (20.3)
Outcome
Use of CBP 5742 5521 (96.2)
Perfusion time (min) 5521 80.7 (26.5)
Crossclamp time (min) 5521 47.9 (17.2)
IABP after surgery 5742 161 (2.8)
Hours in the ICU 5627 22 (19-26)
Need of RRT postoperative 5633 20 (0,4)
Heart failure 5049 231 (4.6)
Postoperative myocardial infarction 5049 96 (1.9)
Postoperative sepsis 5049 62 (1.1)
Postoperative permanent stroke 5049 35 (0.8)
Postoperative atrial fibrillation 5049 1294 (25.6)
Reoperated for bleeding 5740 279 (4.9)
Reoperated for mediastinitis 5740 79 (1.4)
Hemoglobin, preoperative (g/L) 5616 132.4 (15.8)
Hemoglobin at discharge (g/L) 5672 103.4 (11.4)
Erythrocytes transfused 5742 3105 (54)
Plasma transfused 5742 1984 (34.5)
Platelets transfused 5742 694 (12.1)
P-creatinine, preoperative (mmol/L) 5347 86.5 (29.4)
P-creatinine, preoperative including
estimates (mmol/L)
5742 86.4 (29.3)
P-creatinine, peak (mmol/L) 5742 103.8 (51)
P-creatinine at discharge (mmol/L) 5742 90.2 (40.6)
MDRD eGFR, preoperative mL/min/1.73 m2 5742 83.7 (23.8)
MDRD eGFR, peak mL/min/1.73 m2 5742 72.7 (25.8)
MDRD eGFR discharge mL/min/1.73 m2 5742 82.8 (27.1)
(Continued)
TABLE 2. Continued
Characteristic No.
Mean (SD) or
n (%)
CG eCrCl, preoperative mL/min 5741 88.0 (32.9)
CG eCrCl, peak mL/min 5741 77.9 (33.0)
CG eCrCl at discharge mL/min 5742 87.1 (34.9)
CABG, Coronary artery bypass grafting; CBP, cardiopulmonary bypass; CCS, Cana-
dian Cardiovascular Society; CG, Cockroft–Gault formula; COPD, chronic obstruc-
tive pulmonary disease; eCrCl, estimated creatinine clearance; eGFR, estimated
glomerular filtration fate; EuroSCORE, European System for Cardiac Operative
Risk Evaluation; IABP, intra-aortic balloon pump; ICU, intensive care unit; LVEF,
left ventricular ejection fraction; MDRD, Modification of Diet in Renal Disease;
NYHA, New York Heart Association; PCI, percutaneous coronary intervention;
RRT, renal replacement therapy; SD, standard deviation.
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The Journal of Thoracic and CaTo further clarify which time for renal measurement is the
most important, all 3 variables (eGFRpreoperative, eGFRdischarge,
and eGFRpeak)were forced in a separateCoxanalysis, and only
the eGFRpeak values remained significant with an HR of 0.98
(P < .0001; Wald ¼ 41.4). The values for eGFRdischarge
changed to an HR of 1.0 (P¼ .3; Wald¼ 1.1), and the values
for preoperative eGFR changed to an HR of 1.0 (P ¼ .6;
Wald ¼ 0.25).P
MDISCUSSION
In this large single-center cohort of patients with no his-
tory of chronic kidney failure undergoing CABG, we aimed
at assessing different methods of evaluating postoperative
AKI with the RIFLE system and correlating them to long-
termmortality. The eGFRpeak value was a stronger predictor
of death than the eGFRpreoperative or eGFRdischarge. The high-
est number of patients was classified as AKI with the eGFR
method. Patients with a recovered renal function at
discharge had a normalized HR if their AKI was classified
as RIFLE R, but the remaining had an increased mortality
risk if they had recovered from RIFLE I or F.
Both time points for measuring and the dynamics of renal
recovery seem important because the poorest renal function
appears vastly superior in predicting survival. An analysis
was performed in which eGFR from 3 different time points
(preoperative, peak, and discharge) were entered separately
into the Cox regression model, followed by another analysis
in which all eGFR measures were entered at the same time.
The results were the same in both analyses, where eGFRpeak
was indisputably the strongest predictor (HR, 0.98;
P<.0001; Wald¼ 41.4). This corresponds to a risk increase
of 2% for every milliliter/minute decrease in eGFRpeak. To
our knowledge, this has not been reported before. In the
RIFLE classification presented in Tables 3 and 4, we see
that peak levels rather than discharge levels detect more
patients in higher-risk classes (I and F). Moreover, patients
at the lower R risk class had a lower HR. Therefore, our
RIFLE analysis confirms the strength of peak levels.
The results of the survival analysis based on the renal
function estimated from the highest postoperative level ofrdiovascular Surgery c Volume 147, Number 2 803
TABLE 3. Relative risk of mortality (expressed as adjusted hazard ratio) after coronary artery bypass grafting depending on RIFLE class at
poorest measured renal function (RIFLEpeak) during hospital stay
Non-AKI R I F
1 P-creatinine n ¼ 5742 5092 (88.7%) 1.57 (1.31-1.89)
P<.000001
463 (8.1%)
1.62 (1.13-2.33)
P ¼ .009435
103 (1.8%)
1.90 (1.32-2.74)
P ¼ .000600
84 (1.5%)
2 CG eCrCl n ¼ 5735 4147 (72.3%) 1.32 (1.13-1.56)
P ¼ .000716
942 (16.4%)
1.53 (1.23-1.90)
P ¼ .000145
327 (5.7%)
2.03 (2.03-2.53)
P<.000001
319 (5.6%)
3 MDRD eGFR n ¼ 5742 3855 (67.1%) 1.29 (1.09-1.51)
P ¼ .002536
1051 (18.3%)
1.85 (1.51-2.27)
P<.000001
400 (7.0%)
1.85 (1.85-2.26)
P<.000001
436 (7.6%)
The 3 methods used to measure renal function were p-creatinine, the CG formula for creatinine clearance, and MDRD formulae. P values refer to comparison with non-AKI.
AKI, Acute kidney injury; CG, Cockroft–Gault formula; MDRD, Modification of Diet in Renal Disease; eCrCl, estimated creatinine clearance; eGFR, estimated glomerular
filtration fate; RIFLE, Risk, Injury, Failure, Loss, and End-stage.
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Mp-creatinine (p-creatininepeak) were similar to those re-
ported in previous studies,10,11,17 where increasing renal
dysfunction/RIFLE class resulted in increasing risk of
long-term mortality. Hobson and colleagues,10 also using
p-creatininepeak, showed increasing HRs with higher RIFLE
classes. Thus, our data seem to confirm the results of previ-
ous studies. We also studied the predictive value of renal
function measures at discharge from hospital for long-
term survival. Our data indicated poorer survival with
increasing degree of renal dysfunction, where the MDRD
formulae predicted increasing risks of more serious RIFLE
classes, whereas the p-creatinine value did not predict an in-
crease in HR for every RIFLE class (Table 4). On the other
hand, the p-creatininedischarge value was demonstrated to be
of statistically lower strength in predicting death, so the
clinical value of the p-creatininedischarge estimates is there-
fore limited. Our findings are in concordance with previous
studies, in which an association between renal function and
long-term mortality has been shown.19,30 It has also beenTABLE 4. Relative risk of mortality (expressed as hazard ratio) during fo
Non-AKI
1 P-creatinine n ¼ 5742 5579 (97.2%) 1
P
1
2 CG eCrCl n ¼ 5735 5116 (89.2%) 1
P
4
3 MDRD eGFR n ¼ 5742 4920 (85.7%) 1
P
5
The 3methods used tomeasure renal functionwere p-creatinine, theCG formula for creatinin
eCrCl, estimated creatinine clearance; eGFR, estimated glomerular filtration fate;MDRD, M
804 The Journal of Thoracic and Cardiovascular Surgshown that the magnitude and duration of post-cardiac sur-
gery AKI is proportional to long-term mortality.1,10,11,31
The use of eGFR and eCrCl in conjunction with AKI has
been questioned, and caution for the use of these estimates
in the context of AKI has been advocated32-34 given that
these estimations have been developed for patients with
chronic kidney disease and a p-creatinine in steady state,
which is not the case in an AKI scenario. However, these
estimates have been used in conjunction with post cardiac
surgery AKI.8,10,28 A higher sensitivity for RIFLE classes
Risk and Injury in cardiac surgery also has been
suggested using eGFR compared with p-creatinine.33 A
similar finding was made in the present study where the
p-creatininepeak value was evaluated. The number of pa-
tients classified as AKI was higher in the eGFR group
than in the p-creatinine and eCrCl groups. Another impor-
tant piece of the puzzle was findings in a recent study
from our group,16 in which different estimates of renal func-
tion versus iohexol clearance in cardiac surgery werellow-up depending on RIFLE class at discharge (RIFLEdischarge)
R I F
.90 (1.39-2.87)
¼ .000050
23 (2.1%)
2.07 (1.09-3.92)
P ¼ .025779
24 (0.4%)
1.15 (0.57-2.33)
P ¼ .693115
16 (0.3%)
.37 (1.13-1.67)
¼ .001363
42 (7.7%)
2.00 (1.40-2.86)
P ¼ .000160
89 (1.6%)
1.60 (1.12-2.28)
P ¼ .010398
88 (1.5%)
.45 (1.21-1.74)
¼ .000045
61 (9.8%)
1.75 (1.30-2.37)
P ¼ .000275
143 (2.5%)
1.94 (1.43-2.63)
P ¼ .000018
118 (2.0%)
e clearance, andMDRDeGFR.AKI, Acute kidney injury;CG, Cockroft–Gault formula;
odification of Diet in Renal Disease; RIFLE, Risk, Injury, Failure, Loss, and End-stage.
ery c February 2014
FIGURE 1. Unadjusted Kaplan–Meier plot depicting the survival of patients depending on level of AKI stratified by the RIFLE classification based on
MDRD eGFRpeak calculations. AKI, Acute kidney injury; RIFLE, Risk, Injury, Failure, Loss, and End-stage.
Dardashti et al Perioperative Managementevaluated. We found that MDRD eGFR was better than CG
eCrCl in estimating clearance in postoperative patients.16
MDRD eGFR seems to be a robust biomarker for GFR in
patients undergoing cardiac surgery under non—steady-
state conditions. In addition, this study supports that both
eCrCl and eGFR were superior to crude p-creatinine in
identifying patients with AKI after CABG surgery, and
eGFR was slightly superior to eCrCl.
The poorest renal function postoperatively and the renal
function at discharge from hospital can be combined to
assess the impact of these changes in renal function on sur-
vival. RIFLE classes based on MDRD eGFR were used to
create a 2-dimensional matrix with peak and discharge RI-
FLE class. MDRD eGFR was used because this methodTABLE 5. Relative risk of mortality (expressed as hazard ratio) during f
(RIFLEdischarge) and poorest measured renal function (RIFLEpeak)
Non-AKI peak R p
Non-AKI at discharge 3855 (67.1%) 1.18 (0.
P ¼ .08
723 (12
R at discharge 1.49 (1.
P ¼ .00
328 (5.7
I at discharge
F at discharge
Renal function was measured by MDRD eGFR. AKI, Acute kidney injury; RIFLE, Risk,
The Journal of Thoracic and Careflected renal function better than eCrCl and p-creatinine,
as discussed earlier. When analyzing the effect of total re-
covery from any degree of AKI to non-AKI at discharge,
the results were beneficial in terms of survival compared
with patients without RIFLE R recovery. This is in accor-
dance with previous studies.1,4,10,11,19,31 Of note, this was
not true for the groups that had been in RIFLE groups I
and F at the poorest level, with a remaining HR
proportional to the worse degree of AKI. A similar result
was presented by Mehta and colleagues,4 reporting a
slightly increased long-term mortality in the group showing
partial recovery from acute renal failure (HR 1.58 vs 1.42).
Loef and colleagues19 reported an increase in long-term
mortality in patients with AKI, irrespective of postoperativeollow-up depending on the combination of RIFLE class at discharge
eak I peak F peak
98-1.43)
5694
.6%)
1.58 (1.18-2.10)
P ¼ .001975
204 (3.6%)
2.53 (1.84-3.48)
P<.00001
139 (2.4%)
16-1.91)
1891
%)
2.17 (1.59-2.96)
P<.00001
125 (2.2%)
1.19 (0.80-1.76)
P ¼ .382464
107 (1.9%)
1.95 (1.27-3.00)
P ¼ .002285
71 (1.2%)
1.82 (1.18-2.81)
P ¼ .007228
72 (1.3%)
2.07 (1.50-2.85)
P ¼ .000008
118 (2.1%)
Injury, Failure, Loss, and End-stage.
rdiovascular Surgery c Volume 147, Number 2 805
P
M
Perioperative Management Dardashti et al
P
Mrenal recovery. Although stratifying the patients into groups
according to their RIFLE class provides more information
about the effect of recovery, depending on the degree of
AKI at peak p-creatinine level and the degree of recovery
at discharge, the groups become smaller, thus increasing
the uncertainty in the analysis. However, studying the
2-dimensional analysis, we can see that long-term mortality
HR for all patients classified as non-AKI at discharge was
directly proportional to the AKI level at RIFLEpeak for these
patients.
One of the strengths of this study is the database, which
contains information on many perioperative variables,
such as laboratory results and transfusion data. In addition,
many variables had a high completion rate, with more than
99% complete data follow-up. Moreover, the present study
includes only patients undergoing CABG, whereas several
other studies have included a mixed population.31,35 The
lack of baseline p-creatinine in using the RIFLE
classification10 has been highlighted as a limitation.32 Pre-
operative p-creatinine levels were missing in only 1.8%
of our subjects, and we used an imputation technique based
on the p-creatinine level on the first postoperative day,
which has a correlation estimate of 0.89.21 In a post hoc
analysis, we checked the demographics for the patients
who had their preoperative creatinine imputed. These pa-
tients had a slightly higher European System for Cardiac
Operative Risk Evaluation (EuroSCORE) (5.6 vs 4.8) and
a higher frequency of preoperative IABP (3% vs 11%)
but did not differ in any other characteristic. We did not
take into account the time to recovery in our analysis,
although this may be a factor influencing long-term sur-
vival, as reported by Brown and colleagues.1 Although the
study comprises more than 5000 individuals, the numbers
of patients in the more serious classes of renal dysfunction
are relatively small, especially in the 2-dimensional matrix.
This could lead to an overparameterization, which subse-
quently will lead to a risk of over- or underestimation of
the HRs in these small groups. Other limitations are the
single-center, retrospective study, the lack of data on uri-
nary output, and the inherent weaknesses of the MDRD
and CG formula, such as extreme body weight, low GFR,
and age of the cohort. A more accurate measure of GFR
would further strengthen the results of a study of this
type. Today, p-creatinine is the most commonly used
marker for renal function despite its shortcomings, but cys-
tatin C has recently been suggested as a better marker.16CONCLUSIONS
In concordance with previous studies, out study shows
that renal function plays a pivotal role in long-term outcome
in cardiac surgery. The dynamics of renal function during
hospital stay also is an important factor, where recovery
seems to be beneficial, and until better serum markers for806 The Journal of Thoracic and Cardiovascular Surgrenal function are found, eGFR based on the MDRD for-
mula seems to yield the most reliable results. The present
study also suggests that the poorest measured postoperative
renal function is the most predictive for mortality.
The authors thank Peter H€oglund for invaluable help with sur-
vival statistics, Jan Karlsson for developing and maintaining the
primary database, and Max Bell at Karolinska Hospital in Stock-
holm for engaging discussions on the topic.
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